Evidence map›Paper›PMID 35368394›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2022

Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.

Chie Mogi, Masanori Yoshida, Koji Kawano, Takaaki Fukuyama, Toshiro Arai

Open access · greenAbstract read
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Anti-Inflammatory Activity ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Canine immune cells express high levels of CBVeterinary immunology and immunopathology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chie MogiDepartment of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).
Masanori YoshidaDepartment of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).
Koji KawanoDepartment of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).
Takaaki FukuyamaDepartment of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).
Toshiro AraiDepartment of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan (Mogi, Fukuyama); Hidamari Animal Hospital, Kanagawa, Japan (Yoshida); Tokyo Animal Allergy Center, Tokyo, Japan (Kawano); Department of Veterinary Science, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan (Arai).
Nippon Veterinary and Life Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We aimed to examine the effects of cannabidiol (CBD)-containing hemp oil without delta-9-tetrahydrocannabinol (THC) as a supplemental treatment for canine atopic dermatitis (CAD), as well as its adverse effects, and effects on concurrent drug use in dogs. Animal: In this retrospective case series, 8 dogs with CAD were diagnosed by veterinary dermatologists certified by the Japanese Society of Veterinary Dermatology. Procedure: The medical records of dogs supplemented with CBD-containing hemp oil were evaluated with respect to signalment, physical examination, plasma C-reactive protein concentrations, pharmacologic management, the CAD Extent and Severity Index (4th iteration), and the Pruritus Visual Analog Scale. Results: Overall, CBD, used as a supplement in combination with other drugs, was well-tolerated over a wide dose range and decreased the occurrence of pruritus in dogs with CAD when ingested twice a day. Conclusion: This study provides the first report of supplementation with CBD without THC that was effective in controlling pruritic behavior in dogs with CAD. Clinical relevance: Further controlled studies are required to investigate the dose range, efficacy, and safety.

Indexed as

CannabidiolDermatitis, AtopicDog DiseasesAnimalsCannabisDogsDronabinolPlant ExtractsRetrospective StudiesCannabidiolDronabinolhempseed oilPlant Extracts

Identifiers

PMID35368394
PMCPMC8922375
OpenAlexW4226315765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.